The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors
Authors:
- Darina L. LazarovaDLDarina L. Lazarova
- Alan C. SartorelliASAlan C. Sartorelli
- 1 May 2007
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 313 (8) , 1652-1666
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitorProceedings of the National Academy of Sciences, 2006
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Targeting histone deacetylase in cancer therapyMedicinal Research Reviews, 2006
- A Human- and Male-Specific Protocadherin that Acts through the Wnt Signaling Pathway to Induce Neuroendocrine Transdifferentiation of Prostate Cancer CellsCancer Research, 2005
- Ionomycin downregulates β-catenin/Tcf signaling in colon cancer cell lineCarcinogenesis, 2005
- Inhibition of the DNA binding by the TCF-1 binding RNA aptamerBiochemical and Biophysical Research Communications, 2005
- Novel target genes of the Wnt pathway and statistical insights into Wnt target promoter regulationThe FEBS Journal, 2005
- Acetylation of proteins as novel target for antitumor therapy: Review articleAmino Acids, 2004
- Inhibition of Tcf3 Binding by I-mfa Domain ProteinsMolecular and Cellular Biology, 2001
- Regulation of β-Catenin Signaling by the B56 Subunit of Protein Phosphatase 2AScience, 1999